Status:
COMPLETED
Further Studies of Attention Deficit Disorder - Residual Type (RT)
Lead Sponsor:
University of Utah
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Attention Deficit Hyperactivity Disorder
Eligibility:
All Genders
21-55 years
Phase:
PHASE3
Brief Summary
The first phase was a double-blind crossover design of methylphenidate in the treatment of adult ADHD. The second phase consisted of an open-label extension trial of methylphenidate in adult ADHD. It ...
Detailed Description
All patients received a single-blind week on placebo, followed by a double-blind random assignment crossover trial of methylphenidate and placebo, with each double-blind phase lasting two weeks. Subje...
Eligibility Criteria
Inclusion
- Ages 21-55 years; male and female; met "Utah Criteria" for adult ADHD; 95th or higher percentile on the Parent Rating Scale and/or the Wender Utah Rating Scale;
Exclusion
- Patients with other axis-I and axis-II diagnoses were excluded as were patients with significant medical problems.
Key Trial Info
Start Date :
February 1 1986
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 1994
Estimated Enrollment :
116 Patients enrolled
Trial Details
Trial ID
NCT00693212
Start Date
February 1 1986
End Date
November 1 1994
Last Update
June 6 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Univ of Utah, School of Medicine, Mood Disorders Clinic
Salt Lake City, Utah, United States, 84132